| Oxidative stress and Parkinson’s disease J Blesa, I Trigo-Damas, A Quiroga-Varela, VR Jackson-Lewis Frontiers in neuroanatomy 9, 91, 2015 | 945 | 2015 |
| Advances in Parkinson’s disease: 200 years later NLG Del Rey, A Quiroga-Varela, E Garbayo, I Carballo-Carbajal, ... Frontiers in neuroanatomy 12, 113, 2018 | 164 | 2018 |
| What basal ganglia changes underlie the parkinsonian state? The significance of neuronal oscillatory activity A Quiroga-Varela, JR Walters, E Brazhnik, C Marin, JA Obeso Neurobiology of disease 58, 242-248, 2013 | 107 | 2013 |
| Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis M Di Filippo, A de Iure, C Giampà, D Chiasserini, A Tozzi, PL Orvietani, ... Scientific reports 6 (1), 20926, 2016 | 102 | 2016 |
| Alpha-synuclein produces early behavioral alterations via striatal cholinergic synaptic dysfunction by interacting with GluN2D N-methyl-D-aspartate receptor subunit A Tozzi, A de Iure, V Bagetta, M Tantucci, V Durante, A Quiroga-Varela, ... Biological Psychiatry 79 (5), 402-414, 2016 | 99 | 2016 |
| Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration V Durante, A de Iure, V Loffredo, N Vaikath, M De Risi, S Paciotti, ... Brain 142 (5), 1365-1385, 2019 | 97 | 2019 |
| Endogenous 17β-estradiol is required for activity-dependent long-term potentiation in the striatum: interaction with the dopaminergic system A Tozzi, A de Iure, M Tantucci, V Durante, A Quiroga-Varela, C Giampà, ... Frontiers in Cellular Neuroscience 9, 192, 2015 | 58 | 2015 |
| Disrupted salience network dynamics in Parkinson's disease patients with impulse control disorders I Navalpotro-Gomez, J Kim, PM Paz-Alonso, M Delgado-Alvarado, ... Parkinsonism & related disorders 70, 74-81, 2020 | 33 | 2020 |
| Pramipexole-induced impulsivity in mildparkinsonian rats: a model of impulse control disorders in Parkinson's disease H Jiménez-Urbieta, B Gago, A Quiroga-Varela, T Rodríguez-Chinchilla, ... Neurobiology of aging 75, 126-135, 2019 | 28 | 2019 |
| [18F]-DPA-714 PET as a specific in vivo marker of early microglial activation in a rat model of progressive dopaminergic degeneration T Rodríguez-Chinchilla, A Quiroga-Varela, F Molinet-Dronda, ... European Journal of Nuclear Medicine and Molecular Imaging 47, 2602-2612, 2020 | 25 | 2020 |
| Functional inhibitory control dynamics in impulse control disorders in Parkinson's disease PM Paz‐Alonso, I Navalpotro‐Gomez, P Boddy, R Dacosta‐Aguayo, ... Movement Disorders 35 (2), 316-325, 2020 | 25 | 2020 |
| Monoaminergic PET imaging and histopathological correlation in unilateral and bilateral 6-hydroxydopamine lesioned rat models of Parkinson's disease: a longitudinal in-vivo study F Molinet-Dronda, B Gago, A Quiroga-Varela, C Juri, M Collantes, ... Neurobiology of Disease 77, 165-172, 2015 | 24 | 2015 |
| Animal models of Parkinson's disease J Blesa, I Trigo-Damas, A Quiroga-Varela, N Lopez-Gonzalez del Rey IntechOpen, 2016 | 22 | 2016 |
| Striatal synaptic bioenergetic and autophagic decline in premotor experimental parkinsonism L Merino-Galán, H Jimenez-Urbieta, M Zamarbide, ... Brain 145 (6), 2092-2107, 2022 | 19 | 2022 |
| Short-and long-term effects induced by repeated 6-OHDA intraventricular administration: A new progressive and bilateral rodent model of Parkinson’s disease A Quiroga-Varela, E Aguilar, E Iglesias, JA Obeso, C Marin Neuroscience 361, 144-156, 2017 | 18 | 2017 |
| Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases? A Zabalza, G Arrambide, S Otero-Romero, A Pappolla, P Tagliani, ... Multiple Sclerosis Journal 28 (7), 1138-1145, 2022 | 14 | 2022 |
| Association of serum neurofilament light chain levels at disease onset with disability worsening in patients with a first demyelinating multiple sclerosis event not treated … E Monreal, JI Fernández-Velasco, MI García-Sánchez, SS De La Maza, ... JAMA neurology 80 (4), 397-403, 2023 | 13 | 2023 |
| Nigrostriatal dopamine transporter availability, and its metabolic and clinical correlates in Parkinson’s disease patients with impulse control disorders I Navalpotro-Gomez, R Dacosta-Aguayo, F Molinet-Dronda, ... European Journal of Nuclear Medicine and Molecular Imaging 46, 2065-2076, 2019 | 13 | 2019 |
| Striatal spreading depolarization: Possible implication in levodopa‐induced dyskinetic‐like behavior A de Iure, F Napolitano, G Beck, A Quiroga Varela, V Durante, ... Movement Disorders 34 (6), 832-844, 2019 | 8 | 2019 |
| Ratios of proteins in cerebrospinal fluid in Parkinson's disease cognitive decline: prospective study M Delgado‐Alvarado, R Dacosta‐Aguayo, I Navalpotro‐Gómez, B Gago, ... Movement Disorders 33 (11), 1809-1813, 2018 | 8 | 2018 |
Javier Blesa (ORCID 0000-0002-4257...HM CINAC (Centro Integral de Neurociencias), Madrid, SpainGeverifieerd e-mailadres voor hmhospitales.com
